These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation. Kong M; Lee J; Yazdi IK; Miri AK; Lin YD; Seo J; Zhang YS; Khademhosseini A; Shin SR Adv Healthc Mater; 2019 Feb; 8(3):e1801146. PubMed ID: 30609312 [TBL] [Abstract][Full Text] [Related]
5. In Vitro Mechanical Stimulation to Reproduce the Pathological Hallmarks of Human Cardiac Fibrosis on a Beating Chip and Predict The Efficacy of Drugs and Advanced Therapies. Visone R; Paoletti C; Cordiale A; Nicoletti L; Divieto C; Rasponi M; Chiono V; Occhetta P Adv Healthc Mater; 2024 Feb; 13(4):e2301481. PubMed ID: 37941521 [TBL] [Abstract][Full Text] [Related]
6. Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in anti-SSA/Ro-associated congenital heart block. Clancy RM; Markham AJ; Jackson T; Rasmussen SE; Blumenberg M; Buyon JP Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H631-H640. PubMed ID: 28626076 [TBL] [Abstract][Full Text] [Related]
7. Activated Cardiac Fibroblasts Control Contraction of Human Fibrotic Cardiac Microtissues by a β-Adrenoreceptor-Dependent Mechanism. Błyszczuk P; Zuppinger C; Costa A; Nurzynska D; Di Meglio FD; Stellato M; Agarkova I; Smith GL; Distler O; Kania G Cells; 2020 May; 9(5):. PubMed ID: 32443848 [TBL] [Abstract][Full Text] [Related]
8. Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing. Mastikhina O; Moon BU; Williams K; Hatkar R; Gustafson D; Mourad O; Sun X; Koo M; Lam AYL; Sun Y; Fish JE; Young EWK; Nunes SS Biomaterials; 2020 Mar; 233():119741. PubMed ID: 31927251 [TBL] [Abstract][Full Text] [Related]
9. High-Resolution Transcriptomic Profiling of the Heart During Chronic Stress Reveals Cellular Drivers of Cardiac Fibrosis and Hypertrophy. McLellan MA; Skelly DA; Dona MSI; Squiers GT; Farrugia GE; Gaynor TL; Cohen CD; Pandey R; Diep H; Vinh A; Rosenthal NA; Pinto AR Circulation; 2020 Oct; 142(15):1448-1463. PubMed ID: 32795101 [TBL] [Abstract][Full Text] [Related]
10. Activated fibroblasts in cardiac and cancer fibrosis: An overview of analogies and new potential therapeutic options. Nicolini G; Balzan S; Forini F Life Sci; 2023 May; 321():121575. PubMed ID: 36933828 [TBL] [Abstract][Full Text] [Related]
11. TRPV4 deletion protects heart from myocardial infarction-induced adverse remodeling via modulation of cardiac fibroblast differentiation. Adapala RK; Kanugula AK; Paruchuri S; Chilian WM; Thodeti CK Basic Res Cardiol; 2020 Jan; 115(2):14. PubMed ID: 31925567 [TBL] [Abstract][Full Text] [Related]
12. Mechanical stress regulates the mechanotransduction and metabolism of cardiac fibroblasts in fibrotic cardiac diseases. Tian G; Ren T Eur J Cell Biol; 2023 Jun; 102(2):151288. PubMed ID: 36696810 [TBL] [Abstract][Full Text] [Related]
13. Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis. Zhang H; Tian L; Shen M; Tu C; Wu H; Gu M; Paik DT; Wu JC Circ Res; 2019 Aug; 125(5):552-566. PubMed ID: 31288631 [TBL] [Abstract][Full Text] [Related]
14. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling. Li Y; Li Z; Zhang C; Li P; Wu Y; Wang C; Bond Lau W; Ma XL; Du J Circulation; 2017 May; 135(21):2041-2057. PubMed ID: 28249877 [TBL] [Abstract][Full Text] [Related]
15. Cell-Based Mechanosensation, Epigenetics, and Non-Coding RNAs in Progression of Cardiac Fibrosis. Ferrari S; Pesce M Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861579 [TBL] [Abstract][Full Text] [Related]
17. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts. Cho N; Razipour SE; McCain ML Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479 [TBL] [Abstract][Full Text] [Related]
18. Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis. Ragazzini S; Scocozza F; Bernava G; Auricchio F; Colombo GI; Barbuto M; Conti M; Pesce M; Garoffolo G Acta Biomater; 2022 Oct; 152():300-312. PubMed ID: 36055606 [TBL] [Abstract][Full Text] [Related]
19. Novel factors that activate and deactivate cardiac fibroblasts: A new perspective for treatment of cardiac fibrosis. de Oliveira Camargo R; Abual'anaz B; Rattan SG; Filomeno KL; Dixon IMC Wound Repair Regen; 2021 Jul; 29(4):667-677. PubMed ID: 34076932 [TBL] [Abstract][Full Text] [Related]
20. A microscale biomimetic platform for generation and electro-mechanical stimulation of 3D cardiac microtissues. Visone R; Talò G; Occhetta P; Cruz-Moreira D; Lopa S; Pappalardo OA; Redaelli A; Moretti M; Rasponi M APL Bioeng; 2018 Dec; 2(4):046102. PubMed ID: 31069324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]